{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T09:14:08Z","timestamp":1776244448781,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10072-026-08980-y","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:30:37Z","timestamp":1775007037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patent foramen ovale closure versus medical therapy alone in elderly patients with cryptogenic stroke: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"47","author":[{"given":"Ocilio","family":"de Deus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4140-6045","authenticated-orcid":false,"given":"Gabriel Caruso Novaes","family":"Tudella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonia Oliveira Machado","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovana","family":"Menegucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto Utida","family":"Klostermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson Matheus","family":"Pereira da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Pari","family":"Mitre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Scarcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"G\u00fcnkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"8980_CR1","doi-asserted-by":"crossref","unstructured":"Hart RG, Diener H-C, Coutts SB, Easton JD, Granger CB, O\u2019Donnell MJ, et al (2014) Embolic strokes of undetermined source: the case for a new clinical construct. The Lancet Neurology 13:429\u201338","DOI":"10.1016\/S1474-4422(13)70310-7"},{"key":"8980_CR2","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","volume":"67","author":"DM Kent","year":"2016","unstructured":"Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD et al (2016) Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials. J Am Coll Cardiol 67:907\u201317","journal-title":"J Am Coll Cardiol"},{"key":"8980_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.86","volume":"2","author":"S Homma","year":"2016","unstructured":"Homma S, Mess\u00e9 SR, Rundek T, Sun Y-P, Franke J, Davidson K et al (2016) Patent foramen ovale. Nat Rev Dis Primers 2:15086","journal-title":"Nat Rev Dis Primers"},{"key":"8980_CR4","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1212\/WNL.55.8.1172","volume":"55","author":"JR Overell","year":"2000","unstructured":"Overell JR, Bone I, Lees KR (2000) Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55:1172\u20139","journal-title":"Neurology"},{"key":"8980_CR5","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1161\/STROKEAHA.109.547828","volume":"40","author":"AA Alsheikh-Ali","year":"2009","unstructured":"Alsheikh-Ali AA, Thaler DE, Kent DM (2009) Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke 40:2349\u201355","journal-title":"Stroke"},{"key":"8980_CR6","doi-asserted-by":"crossref","unstructured":"Caso V, Turc G, Abdul-Rahim AH, Castro P, Hussain S, Lal A, et al (2024) European Stroke Organisation (ESO) Guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke. Eur Stroke J 9:800\u201334.","DOI":"10.1177\/23969873241247978"},{"key":"8980_CR7","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D et al (2021) 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association. Stroke 52:e364\u2013467","journal-title":"Stroke"},{"key":"8980_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jscai.2022.100039","author":"CJ Kavinsky","year":"2022","unstructured":"Kavinsky CJ, Szerlip M, Goldsweig AM, Amin Z, Boudoulas KD, Carroll JD et al (2022) SCAI guidelines for the management of patent foramen ovale. Journal of the Society for Cardiovascular Angiography & Interventions. https:\/\/doi.org\/10.1016\/j.jscai.2022.100039","journal-title":"Journal of the Society for Cardiovascular Angiography & Interventions"},{"key":"8980_CR9","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jamaneurol.2020.1948","volume":"77","author":"S Mazzucco","year":"2020","unstructured":"Mazzucco S, Li L, Rothwell PM (2020) Prognosis of cryptogenic stroke with patent foramen ovale at older ages and implications for trials: a population-based study and systematic review. JAMA Neurol 77:1279\u201387","journal-title":"JAMA Neurol"},{"key":"8980_CR10","doi-asserted-by":"crossref","unstructured":"Lee PH, Kim J-S, Song J-K, Kwon SU, Kim BJ, Lee JS, et al (2024) Device Closure or Antithrombotic Therapy After Cryptogenic Stroke in Elderly Patients With a High-Risk Patent Foramen Ovale. J Stroke 26:242\u201351","DOI":"10.5853\/jos.2023.03265"},{"key":"8980_CR11","doi-asserted-by":"crossref","unstructured":"Chen P-L, Wang C-S, Huang J-A, Fu Y-C, Liao N-C, Hsu C-Y, et al (2023) Patent foramen ovale closure in non-elderly and elderly patients with cryptogenic stroke: a hospital-based cohort study. Front Neurol 14:1190011","DOI":"10.3389\/fneur.2023.1190011"},{"key":"8980_CR12","doi-asserted-by":"crossref","unstructured":"Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, et al (2004) Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 44:750\u20138","DOI":"10.1016\/j.jacc.2004.05.044"},{"key":"8980_CR13","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2019) Cochrane Handbook for Systematic Reviews of Interventions. 2nd Edition. Chichester (UK): John Wiley & Sons (eds)","DOI":"10.1002\/9781119536604"},{"key":"8980_CR14","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71.","DOI":"10.1136\/bmj.n71"},{"key":"8980_CR15","doi-asserted-by":"crossref","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919","DOI":"10.1136\/bmj.i4919"},{"key":"8980_CR16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u201358","journal-title":"Stat Med"},{"key":"8980_CR17","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.amjcard.2018.02.021","volume":"121","author":"A Smer","year":"2018","unstructured":"Smer A, Salih M, Mahfood Haddad T, Guddeti R, Saadi A, Saurav A et al (2018) Meta-analysis of randomized controlled trials on patent foramen ovale closure versus medical therapy for secondary prevention of cryptogenic stroke. Am J Cardiol 121:1393\u20139","journal-title":"Am J Cardiol"},{"key":"8980_CR18","doi-asserted-by":"crossref","unstructured":"Ahmad Y, Howard JP, Arnold A, Shin MS, Cook C, Petraco R, et al (2018) Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials. Eur Heart J 39:1638\u201349","DOI":"10.1093\/eurheartj\/ehy121"},{"key":"8980_CR19","doi-asserted-by":"publisher","DOI":"10.15420\/usc.2020.40","volume":"15","author":"C Vazquez-Sosa","year":"2021","unstructured":"Vazquez-Sosa C, Clegg SD, Blankenship JC (2021) How old is too old? Closure of patent foramen ovale in older patients. US Cardiol 15:e20","journal-title":"US Cardiol"},{"key":"8980_CR20","doi-asserted-by":"crossref","unstructured":"Satpathy R, Rod\u00e9s-Cabau J, Thaler DE, Kent DM, Turner S, Potluri S, et al (2025) PFO Device Closure in Patients\u2009>\u200960 Years of Age With Ischemic Stroke: Results From U.S. Medicare Beneficiaries. JACC Cardiovasc Interv 18:1303\u201314","DOI":"10.1016\/j.jcin.2025.03.034"},{"key":"8980_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.121.011652","volume":"15","author":"A Alperi","year":"2022","unstructured":"Alperi A, Guedeney P, Horlick E, Nombela-Franco L, Freixa X, Pascual I et al (2022) Transcatheter closure of patent foramen ovale in older patients with cryptogenic thromboembolic events. Circ Cardiovasc Interv 15:e011652","journal-title":"Circ Cardiovasc Interv"},{"key":"8980_CR22","doi-asserted-by":"crossref","unstructured":"Wang AY, Rothwell PM, Nelson J, Saver JL, Kasner SE, Carroll J, et al (2024) Patent Foramen Ovale Closure in Older Patients With Stroke: Patient Selection for Trial Feasibility. Neurology 102:e209388","DOI":"10.1212\/WNL.0000000000209388"},{"key":"8980_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/23969873251341764","author":"C-S Wang","year":"2025","unstructured":"Wang C-S, Wu Y-H, Fu Y-C, Jan S-L, Lin M-C, Hsu C-Y et al (2025) Assessment of patent foramen ovale closure in elderly patients with cryptogenic transient ischemic attack or stroke: efficacy, safety, and potential age-related benefit. Eur Stroke J. https:\/\/doi.org\/10.1177\/23969873251341764","journal-title":"Eur Stroke J"},{"key":"8980_CR24","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1161\/STROKEAHA.120.030293","volume":"52","author":"J-J Chen","year":"2021","unstructured":"Chen J-J, Thijs VN (2021) Atrial fibrillation following patent foramen ovale closure: systematic review and meta-analysis of observational studies and clinical trials. Stroke 52:1653\u201361","journal-title":"Stroke"},{"key":"8980_CR25","doi-asserted-by":"crossref","unstructured":"Eichelmann A, Kubini R, Nachoski D, Kosinski C, Becker M, Aljalloud A. Patent foramen ovale closure versus drug therapy in patients over 60 years and a follow-up of 5 years. Clin Cardiol. 2024;47(3):e24251.","DOI":"10.1002\/clc.24251"},{"key":"8980_CR26","unstructured":"Kwon H, Lee PH, Song JK, Kwon SU, Kang DW, Kim JS. Patent Foramen Ovale Closure in Old Stroke Patients: A Subgroup Analysis of the DEFENSE-PFO Trial. J Stroke."},{"key":"8980_CR27","doi-asserted-by":"crossref","unstructured":"Wahl A, J\u00fcni P, Mono ML, et al. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation. 2012;125(6):803-812.","DOI":"10.1161\/CIRCULATIONAHA.111.030494"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08980-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-08980-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08980-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T08:39:13Z","timestamp":1776242353000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-08980-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["8980"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-08980-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study is a review of published literature and does not involve human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors reviewed the final version, contributed to data interpretation, and approved the manuscript for submission. G. C. N. Tudella had full access to all data and assumes responsibility for the study design, data integrity, and the decision to submit for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable. No patient-level data were used in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent Statement"}},{"value":"All figures, tables, and data reproduced from other sources are properly cited. Permission was obtained where required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}},{"value":"G.C.N.T. (Corresponding Author) accepts full responsibility for the work, had access to all the data, and controlled the decision to publish.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"T.N. is an Associate Editor of Stroke; advisory board for Brainomix, Aruna Bio; speaker for Genentech, Kaneka; consultant for Medtronic. L.S. reports conflicts of interest with Penumbra (payment for reading). All other authors have no conflicts of interest.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"394"}}